Astrana Health, Inc.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US03763A2078
USD
41.20
1.61 (4.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
AMN Healthcare Services, Inc.
Astrana Health, Inc.
Quest Diagnostics, Inc.
Laboratory Corp. of America Holdings
IQVIA Holdings, Inc.
Psychemedics Corp.
Teladoc Health, Inc.
Select Medical Holdings Corp.
Premier, Inc.
National Research Corp.

Why is Astrana Health, Inc. ?

1
High Management Efficiency with a high ROE of 19.00%
2
The company is Net-Debt Free
3
Healthy long term growth as Net Sales has grown by an annual rate of 35.87%
4
With a growth in Net Profit of 140.64%, the company declared Very Positive results in Mar 26
  • OPERATING CASH FLOW(Y) Highest at USD 166.03 MM
  • CASH AND EQV(HY) Highest at USD 907.97 MM
  • NET SALES(Q) Highest at USD 965.1 MM
5
High Institutional Holdings at 60.1%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Market Beating Performance
  • The stock has generated a return of 64.96% in the last 1 year, much higher than market (S&P 500) returns of 25.22%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Astrana Health, Inc. should be less than 10%
  2. Overall Portfolio exposure to Miscellaneous should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Astrana Health, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Astrana Health, Inc.
64.34%
0.01
73.61%
S&P 500
22.24%
1.91
13.23%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
35.87%
EBIT Growth (5y)
-0.49%
EBIT to Interest (avg)
9.93
Debt to EBITDA (avg)
0.40
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
1.65
Tax Ratio
40.84%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
60.10%
ROCE (avg)
20.10%
ROE (avg)
19.00%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
58
Industry P/E
Price to Book Value
1.75
EV to EBIT
25.20
EV to EBITDA
15.92
EV to Capital Employed
1.42
EV to Sales
0.62
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.62%
ROE (Latest)
3.02%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

27What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 166.03 MM

CASH AND EQV(HY)

Highest at USD 907.97 MM

NET SALES(Q)

Highest at USD 965.1 MM

OPERATING PROFIT(Q)

Highest at USD 44.01 MM

OPERATING PROFIT MARGIN(Q)

Highest at 4.56 %

PRE-TAX PROFIT(Q)

Highest at USD 18.62 MM

NET PROFIT(Q)

Highest at USD 13.71 MM

EPS(Q)

Highest at USD 0.29

-9What is not working for the Company
INTEREST(HY)

At USD 33.62 MM has Grown at 118.64%

RAW MATERIAL COST(Y)

Grown by 11.08% (YoY

Here's what is working for Astrana Health, Inc.

Pre-Tax Profit
At USD 18.62 MM has Grown at 87.8%
over average net sales of the previous four periods of USD 9.92 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 13.71 MM has Grown at 149.51%
over average net sales of the previous four periods of USD 5.5 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD 166.03 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 965.1 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Sales
At USD 965.1 MM has Grown at 21.33%
over average net sales of the previous four periods of USD 795.44 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Operating Profit
Highest at USD 44.01 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 4.56 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 18.62 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD 13.71 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD 0.29
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Cash and Eqv
Highest at USD 907.97 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Astrana Health, Inc.

Interest
At USD 33.62 MM has Grown at 118.64%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Raw Material Cost
Grown by 11.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales